Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Mindfulness Training and Wristwatch Sensors During Pregnancy

Tests mindfulness training and a wearable watch in pregnant adults at risk of preeclampsia.

Plain-language title generated from the registry record
Registry title: Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy

Key facts

Where
Milwaukee and Providence, United StatesSee the 2 sites

Where in United States

  • Medical College of WisconsinMilwaukee, United StatesTaking people
  • Brown UniversityProvidence, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical College of Wisconsin
Trial code
NCT07218237
Record updated
16 September 2026
Original description
The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.Read full original descriptionShow less

Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy Study: MINDBP

The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.

Inclusion: Pregnant patients at gestational age <= 16 weeks; Live, non-anomalous gestation; Normotensive at enrollment; Meet criteria consistent with 'moderate' to 'high' risk for preeclampsia based on ACOG/USPSTF guidelines for low-dose aspirin administration to prevent hypertensive disorders of pregnancy.

Exclusion: Chronic (pregestational hypertension); Multiple gestation; Inability of unwillingness to provide informed consent; Active suicidality or psychosis; Ongoing mind-body practice (e.g., yoga, meditation, mindfulness >= once per week).

ClinicalTrials.gov NCT07218237